IFNG and Miyoshi myopathy: When NK92-44-1 was added to primary bone marrow target cells from two different MM patients, the addition of mAb 14-25-9 significantly increased IFN-γ levels in assay media, as compared to the addition of control mouse IgG1 (Figure 5A).